Innovation for Health - 13 February 2020
Contact Investor Forum I4H Bootcamp
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Els Beirnaert

CEO, Aelin Therapeutics

Els Beirnaert, PhD and CEO of Aelin Therapeutics, brings along 19 years of experience in drug development, venture and business development. Previously she was one of the start-up pioneers of Ablynx a company established in 2001 focused on biological therapeutics. She was leading multidisciplinary project teams and translating several drug development projects from discovery to clinical development (Phase 1 and 2). Since 2010, she was Head of New Ventures at VIB responsible for the establishment of multiple start-up companies in life sciences. She served in the board of directors of Confo Therapeutics, Q-Biologicals and Multiplicom. Dr. Beirnaert obtained a Master in Biotechnology at the University of Ghent and a PhD in Biochemistry at the Institute of Tropical medicine (University of Antwerp).
Dharminder Chalal
SkylineDx
Marcel Levi
University College London Hospitals
Michel Dumontier
Maastricht University
Thijn Brummelkamp
Scenic Biotech
Hans Schikan
Topsector Life Sciences & Health
Inge Huitinga
Netherlands Brain Bank
Sjaak Vink
TheSocialMedwork
Annemarie Jorritsma
NVP
Wiro Niessen
Erasmus MC, TU Delft & Quantib
Tim Knotnerus
AgomAb Therapeutics
Elise Meijer
Antwerp Management School & Accenture Strategy
Esther Talboom-Kamp
Saltro Diagnostics
Joep Muijrers
PureTech Health
Els Beirnaert
Aelin Therapeutics
Carine van den Brink
Axon Lawyers

Claudia Rijcken
pharmi

Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix
Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Gold sponsor
Silver sponsor
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.